Dowpharma is Boosted by Take-Up of Pfenex Platform

Dowpharma, Dow Chemical’s business unit that offers services and products to the pharmaceuticals sector, is starting to enjoy commercial success on several fronts for its Pfenex biotechnology platform, the company tells CW. Pfenex is used to manufacture therapeutic proteins, dubbed biologic drugs, and enzymes for producing small-molecule drug intermediates. Pfenex: Focusing on a high-yield opportunity. Pfenex technology is based on pseudomonas fluorescens, a bacterium that is able to produce enzymes that undertake various biotransformations. Dowpharma says...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers